Liquidia (LQDA) Profit After Tax (2020 - 2026)
Liquidia (LQDA) posted Profit After Tax of $74.7 million for Q2 2026, up 41.35% on a QoQ basis from $52.9 million in Q1 2026, and up 279.71% year-over-year from $19.7 million in Q2 2025.
Analysis
Liquidia (LQDA) Profit After Tax (2020 - 2026) Analysis & Trends
Liquidia has reported Profit After Tax for 7 years, with the latest figure at $74.7 million in Q2 2026.
- On a quarterly basis, Profit After Tax rose 279.71% year-over-year to $74.7 million in Q2 2026; TTM through Jun 2026 was $138.6 million, a 192.73% increase from a year earlier, with the FY2025 full-year figure at -$68.9 million, up 46.28% from the prior year.
- Profit After Tax was $74.7 million for Q2 2026 at Liquidia, up from $52.9 million in the prior quarter.
- The five-year high for Profit After Tax was $74.7 million in Q2 2026, with the low at -$41.6 million in Q2 2025.
- Average Profit After Tax over 5 years is -$10.5 million, with a median of -$15.9 million recorded in 2022.
- The sharpest annual moves came in 2023 and 2026: Profit After Tax sank 320.17% in 2023, then jumped 279.71% in 2026.
- Over 5 years, Profit After Tax stood at -$6.5 million in 2022, then tumbled by 320.17% to -$27.4 million in 2023, then tumbled by 40.32% to -$38.5 million in 2024, then soared by 137.84% to $14.6 million in 2025, then surged by 412.64% to $74.7 million in 2026.
- The last three Profit After Tax figures came in at $74.7 million (Q2 2026), $52.9 million (Q1 2026), and $14.6 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.50 Bn | 622.74 Bn | 17.26 Bn | 5.53 Bn |
| 2 | AbbVie | 440.29 Bn | 433.72 Bn | 12.70 Bn | 3.62 Bn |
| 3 | Merck | 364.93 Bn | 357.79 Bn | 12.21 Bn | -1.34 Bn |
| 4 | Novartis Ag | 266.65 Bn | 258.96 Bn | 11.24 Bn | 3.26 Bn |
| 5 | Pfizer | 158.92 Bn | 147.22 Bn | 10.94 Bn | -248.00 Mn |
| 6 | Sanofi | 52.46 Bn | 45.08 Bn | 10.79 Bn | 438.21 Mn |
| 7 | Revolution Medicines | 44.32 Bn | 44.32 Bn | - | -644.37 Mn |
| 8 | Incyte | 25.32 Bn | 20.78 Bn | 1.57 Bn | 585.61 Mn |
| 9 | United Therapeutics | 21.42 Bn | 18.75 Bn | 683.80 Mn | 333.00 Mn |
| 10 | Liquidia | 6.09 Bn | 5.80 Bn | 160.92 Mn | 74.72 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 74.72 Mn |
| Mar 31, 2026 | 52.86 Mn |
| Dec 31, 2025 | 14.58 Mn |
| Sep 30, 2025 | -3.53 Mn |
| Jun 30, 2025 | -41.58 Mn |
| Mar 31, 2025 | -38.37 Mn |
| Dec 31, 2024 | -38.52 Mn |
| Sep 30, 2024 | -31.03 Mn |
| Jun 30, 2024 | -28.67 Mn |
| Mar 31, 2024 | -30.08 Mn |
| Dec 31, 2023 | -27.45 Mn |
| Sep 30, 2023 | -15.79 Mn |
| Jun 30, 2023 | -23.52 Mn |
| Mar 31, 2023 | -11.75 Mn |
| Dec 31, 2022 | -6.53 Mn |
| Sep 30, 2022 | -9.09 Mn |
| Jun 30, 2022 | -9.45 Mn |
| Mar 31, 2022 | -15.94 Mn |
| Dec 31, 2021 | -11.56 Mn |
| Sep 30, 2021 | -7.28 Mn |